136 related articles for article (PubMed ID: 37236831)
1. Population-based impact of COVID-19 on incidence, treatment, and survival of patients with pancreatic cancer.
Graus MUJE; de Hingh IHJT; Besselink MG; Bruno MJ; Wilmink JW; de Meijer VE; van Velthuysen MF; Valkenburg-van Iersel LBJ; van der Geest LGM; de Vos-Geelen J; ; ;
HPB (Oxford); 2023 Oct; 25(10):1195-1202. PubMed ID: 37236831
[TBL] [Abstract][Full Text] [Related]
2. Impact of the COVID-19 Pandemic on Colorectal Cancer Care in the Netherlands: A Population-based Study.
Meijer J; Elferink MAG; van Hoeve JC; Buijsen J; van Erning F; Nagtegaal ID; Tanis PJ; Vink GR; Wumkes ML; de Hingh IHJT; Siesling S;
Clin Colorectal Cancer; 2022 Sep; 21(3):e171-e178. PubMed ID: 35346605
[TBL] [Abstract][Full Text] [Related]
3. Limited impact of the COVID-19 pandemic on colorectal cancer care in the Netherlands in 2020.
Meijer J; Elferink MAG; Vink GR; Sijtsma FPC; Buijsen J; Nagtegaal ID; Tanis PJ; Wumkes ML; de Hingh IHJT; Siesling S;
Int J Colorectal Dis; 2022 Sep; 37(9):2013-2020. PubMed ID: 35986108
[TBL] [Abstract][Full Text] [Related]
4. Trends in pancreatic cancer incidence, characteristics, and outcomes in Denmark 1980-2019: A nationwide cohort study.
Kirkegård J; Bojesen AB; Nielsen MF; Mortensen FV
Cancer Epidemiol; 2022 Oct; 80():102230. PubMed ID: 35901622
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors for survival in pancreatic cancer: a population-based study.
Eloubeidi MA; Desmond RA; Wilcox CM; Wilson RJ; Manchikalapati P; Fouad MM; Eltoum I; Vickers SM
Am J Surg; 2006 Sep; 192(3):322-9. PubMed ID: 16920426
[TBL] [Abstract][Full Text] [Related]
6. Volume matters in the systemic treatment of metastatic pancreatic cancer: a population-based study in the Netherlands.
Haj Mohammad N; Bernards N; Besselink MG; Busch OR; Wilmink JW; Creemers GJ; De Hingh IH; Lemmens VE; van Laarhoven HW
J Cancer Res Clin Oncol; 2016 Jun; 142(6):1353-60. PubMed ID: 26995276
[TBL] [Abstract][Full Text] [Related]
7. The impact of the COVID-19 pandemic upon pancreatic cancer treatment (CONTACT Study): a UK national observational cohort study.
Hall LA; McKay SC; Halle-Smith J; Soane J; Osei-Bordom DC; Goodburn L; Magill L; Pinkney T; Radhakrishna G; Valle JW; Corrie P; Roberts KJ;
Br J Cancer; 2023 May; 128(10):1922-1932. PubMed ID: 36959376
[TBL] [Abstract][Full Text] [Related]
8. Impact of the COVID-19 Pandemic on Management of Patients with Metastatic Pancreatic Ductal Adenocarcinoma in the United States.
Paluri R; Laursen A; Gaeta J; Wang S; Surinach A; Cockrum P
Oncologist; 2022 Jun; 27(6):e518-e523. PubMed ID: 35285490
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic cancer: incidence, treatment and survival trends--1175 cases in Calvados (France) from 1978 to 2002.
Lefebvre AC; Maurel J; Boutreux S; Bouvier V; Reimund JM; Launoy G; Arsene D
Gastroenterol Clin Biol; 2009; 33(10-11):1045-51. PubMed ID: 19773140
[TBL] [Abstract][Full Text] [Related]
10. Incidence, Treatment, and Survival of Synchronous Peritoneal Metastases in Pancreatic Cancer: Update of a Nationwide Cohort.
Rijken A; Bakkers C; van Erning FN; van der Geest LG; de Vos-Geelen J; Besselink MG; Lemmens VE; de Hingh IHJT;
Pancreas; 2021 Jul; 50(6):827-833. PubMed ID: 34347730
[TBL] [Abstract][Full Text] [Related]
11. The use of adjuvant chemotherapy for pancreatic cancer varies widely between hospitals: a nationwide population-based analysis.
Bakens MJ; van der Geest LG; van Putten M; van Laarhoven HW; Creemers GJ; Besselink MG; Lemmens VE; de Hingh IH;
Cancer Med; 2016 Oct; 5(10):2825-2831. PubMed ID: 27671746
[TBL] [Abstract][Full Text] [Related]
12. Impact of statin use on survival in patients undergoing resection for early-stage pancreatic cancer.
Wu BU; Chang J; Jeon CY; Pandol SJ; Huang B; Ngor EW; Difronzo AL; Cooper RM
Am J Gastroenterol; 2015 Aug; 110(8):1233-9. PubMed ID: 26195180
[TBL] [Abstract][Full Text] [Related]
13. Survival Trends for Resectable Pancreatic Cancer Using a Multidisciplinary Conference: the Impact of Post-operative Chemotherapy.
Syed AR; Carleton NM; Horne Z; Dhawan A; Bedi G; Kochhar G; Morrissey S; Williams H; Atkinson D; Schiffman S; Monga D; Lupetin A; Kirichenko A; Mitre M; Dhawan M; Kulkarni A; Thakkar S
J Gastrointest Cancer; 2020 Sep; 51(3):836-843. PubMed ID: 31605289
[TBL] [Abstract][Full Text] [Related]
14. Impact of nationwide enhanced implementation of best practices in pancreatic cancer care (PACAP-1): a multicenter stepped-wedge cluster randomized controlled trial.
Mackay TM; Smits FJ; Latenstein AEJ; Bogte A; Bonsing BA; Bos H; Bosscha K; Brosens LAA; Hol L; Busch ORC; Creemers GJ; Curvers WL; den Dulk M; van Dieren S; van Driel LMJW; Festen S; van Geenen EJM; van der Geest LG; de Groot DJA; de Groot JWB; Haj Mohammad N; Haberkorn BCM; Haver JT; van der Harst E; Hemmink GJM; de Hingh IH; Hoge C; Homs MYV; van Huijgevoort NC; Jacobs MAJM; Kerver ED; Liem MSL; Los M; Lubbinge H; Luelmo SAC; de Meijer VE; Mekenkamp L; Molenaar IQ; van Oijen MGH; Patijn GA; Quispel R; van Rijssen LB; Römkens TEH; van Santvoort HC; Schreinemakers JMJ; Schut H; Seerden T; Stommel MWJ; Ten Tije AJ; Venneman NG; Verdonk RC; Verheij J; van Vilsteren FGI; de Vos-Geelen J; Vulink A; Wientjes C; Wit F; Wessels FJ; Zonderhuis B; van Werkhoven CH; van Hooft JE; van Eijck CHJ; Wilmink JW; van Laarhoven HWM; Besselink MG;
Trials; 2020 Apr; 21(1):334. PubMed ID: 32299515
[TBL] [Abstract][Full Text] [Related]
15. No changes in clinical presentation, treatment strategies and survival of pancreatic cancer cases during the SARS-COV-2 outbreak: A retrospective multicenter cohort study on real-world data.
Kempf E; Priou S; Lamé G; Laurent A; Guével E; Tzedakis S; Bey R; Fuks D; Chatellier G; Tannier X; Galula G; Flicoteaux R; Daniel C; Tournigand C;
Int J Cancer; 2023 Dec; 153(12):1988-1996. PubMed ID: 37539961
[TBL] [Abstract][Full Text] [Related]
16. The COVID - AGICT study: COVID-19 and advanced gastro-intestinal cancer surgical treatment. A multicentric Italian study on the SARS-CoV-2 pandemic impact on gastro-intestinal cancers surgical treatment during the 2020. Analysis of perioperative and short-term oncological outcomes.
Giuliani G; Guerra F; Messinese S; Santelli F; Salvischiani L; Esposito S; Ferraro L; Esposito A; De Pastena M; Rega D; Delrio P; La Raja C; Spinelli A; Massaron S; De Nardi P; Kauffmann EF; Boggi U; Deidda S; Restivo A; Marano A; Borghi F; Piccoli M; Depalma N; D'Ugo S; Spampinato M; Cozzani F; Del Rio P; Marcellinaro R; Carlini M; De Rosa R; Scabini S; Maiello F; Polastri R; Turri G; Pedrazzani C; Zese M; Parini D; Casaril A; Moretto G; De Leo A; Catarci M; Trapani R; Zonta S; Marsanic P; Muratore A; Di Franco G; Morelli L; Coppola A; Caputo D; Andreuccetti J; Pignata G; Mastrangelo L; Jovine E; Mazzola M; Ferrari G; Mariani L; Ceccarelli G; Giuseppe R; Bolzon S; Grasso M; Testa S; Germani P; de Manzini N; Langella S; Ferrero A; Coletta D; Bianchi PP; Bengala C; Coratti A;
Surg Oncol; 2023 Apr; 47():101907. PubMed ID: 36924550
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic cancer surgery in elderly patients: Balancing between short-term harm and long-term benefit. A population-based study in the Netherlands.
van der Geest LG; Besselink MG; van Gestel YR; Busch OR; de Hingh IH; de Jong KP; Molenaar IQ; Lemmens VE
Acta Oncol; 2016; 55(3):278-85. PubMed ID: 26552841
[TBL] [Abstract][Full Text] [Related]
18. Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma.
Latenstein AEJ; van der Geest LGM; Bonsing BA; Groot Koerkamp B; Haj Mohammad N; de Hingh IHJT; de Meijer VE; Molenaar IQ; van Santvoort HC; van Tienhoven G; Verheij J; Vissers PAJ; de Vos-Geelen J; Busch OR; van Eijck CHJ; van Laarhoven HWM; Besselink MG; Wilmink JW;
Eur J Cancer; 2020 Jan; 125():83-93. PubMed ID: 31841792
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant therapy versus upfront surgery for resected pancreatic adenocarcinoma: A nationwide propensity score matched analysis.
de Geus SW; Eskander MF; Bliss LA; Kasumova GG; Ng SC; Callery MP; Tseng JF
Surgery; 2017 Mar; 161(3):592-601. PubMed ID: 28341441
[TBL] [Abstract][Full Text] [Related]
20. Sex, Gender and Age Differences in Treatment Allocation and Survival of Patients With Metastatic Pancreatic Cancer: A Nationwide Study.
Pijnappel EN; Schuurman M; Wagner AD; de Vos-Geelen J; van der Geest LGM; de Groot JB; Koerkamp BG; de Hingh IHJT; Homs MYV; Creemers GJ; Cirkel GA; van Santvoort HC; Busch OR; Besselink MG; van Eijck CHJ; Wilmink JW; van Laarhoven HWM
Front Oncol; 2022; 12():839779. PubMed ID: 35402271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
